More Major Players Join 'Farmer-centric' Research on Biologicals

"Biologicals: Farmer Value, Perception and Potential," a comprehensive market research effort focused on understanding farmer opinions on the current use, issues and potential for biologicals at field-level and based in Columbus, Ohio, has announced the support of another six major players.

"We're pleased to announce that Evoia, the Biological Products Industry Alliance (BPIA), Certis, AMVAC, Lalleman and Redox have joined our forces," said Cam Camfield, founder and CEO of Stratovation Group in announcing the news. "We think more good input from more players at the front end will help us gain better data and deeper insight throughout the study. And better data and insight will drive better planning and results for every organization involved."

"Biologicals: Farmer Value, Perception and Potential" kicked off in 2022 and is set to occur annually. Conducted by Stratovation Group, in close collaboration with the Agricultural Retailers Association (ARA), DC Legislative and Regulatory Services (DCLRS) and The Fertilizer Institute (TFI), the repeating study will benchmark adoption and attitudes around farm use of biologicals and aid those seeking to grow and develop the market category. Earlier this summer, Meristem, BASF, Indigo and Pivot Bio joined the effort, and now six more.

"I think it shows how fast ag biologicals are being developed and the great business value it represents to the industry of agriculture," said Camfield. "While there are other reports that may help in broad trend analysis, they lack the farmer voice. In contrast, our team is laser-focused on finding out more about the farmer experience and opinions at field-level.

"Camfield stressed that those interested in joining the effort to produce the "Biologicals: Farmer Value, Perception and Potential" annual report can become a sponsoring partner and share in all the findings, including the raw data. "It's good for us to have more voices involved to inform this study and there's still room for more," he said. "We are gearing up for excellence and inviting any biological-focused company, startup, investor and others to join us," he said.